Labcyte Receives 19th and 20th Patents for Acoustic Droplet Ejection Applications

03-Jun-2005

Labcyte Inc. has received its 19th patent and 20th patents. U.S. Patent 6,893,115 discloses the use of frequency and acoustic pulse time adjustments to maintain consistent droplet size when solvent composition varies. This technology is one of the factors contributing to the high reproducibility of the Echo(TM) 550 compound reformatter, which transfers low nL amounts of library compound solutions. The Echo 550 is now being used by six major pharmaceutical companies to eliminate the need for intermediate dilutions, disposable tips and washing steps involved in preparation of assay plates.

U.S. Patent 6,893, 836 describes the use of focused acoustic energy to eject live cells suspended in a fluid to make patterns of cells on surfaces. Labcyte anticipates using cell dispensing technology to facilitate efficient use of cells for drug discovery, epitope mapping and selection of transformed bacteria, as well as other applications. Cell arrays may be placed the bottom of microwell plates to facilitate screening with multiple cells lines simultaneously and to create engineered tissues.

https://www.bionity.com/en/news/46498/labcyte-receives-19th-and-20th-patents-for-acoustic-droplet-ejection-applications.html